Analysis of induced pluripotent stem cells from a BRCA1 mutant family

Stem Cell Reports

Volumn 1, Issue 4, 2013, Pages 336-349

  Soyombo, Abigail A ^a   Wu, Yipin ^a   Kolski, Lauren ^a   Rios, Jonathan J ^b   Rakheja, Dinesh ^a   Chen, Alice ^c   Kehler, James ^c   Hampel, Heather ^d   Coughran, Alanna ^a   Ross, Theodora S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^c Stemgent   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; MESSENGER RNA; PROTEIN KINASE C THETA; ISOENZYME; PRKCQ PROTEIN, HUMAN; PROTEIN KINASE C;

ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; FIBROBLAST; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BIOPSY; TERATOMA; WILD TYPE; CELL CULTURE; CELL LINE; CYTOLOGY; DNA SEQUENCE; FEMALE; GENETICS; HETEROZYGOTE; HUMAN GENOME; METABOLISM; MUTATION; PEDIGREE;

BRCA1 PROTEIN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENOME, HUMAN; HETEROZYGOTE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISOENZYMES; MUTATION; PEDIGREE; PROTEIN KINASE C; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TERATOMA;

EID: 84886085825     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2013.08.004     Document Type: Article

References (49)

1. F. Anokye-Danso, C.M. Trivedi, D. Juhr, M. Gupta, Z. Cui, Y. Tian, Y. Zhang, W. Yang, P.J. Gruber, J.A. Epstein, and E.E. Morrisey Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency Cell Stem Cell 8 2011 376 388
2. R. Baer, and T. Ludwig The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity Curr. Opin. Genet. Dev. 12 2002 86 91
3. K. Belguise, and G.E. Sonenshein PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis J. Clin. Invest. 117 2007 4009 4021
4. K. Belguise, S. Milord, F. Galtier, G. Moquet-Torcy, M. Piechaczyk, and D. Chalbos The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells Oncogene 31 2012 4889 4897
5. P. Blay, A. Astudillo, J.M. Buesa, E. Campo, M. Abad, J. García-García, R. Miquel, V. Marco, M. Sierra, and R. Losa Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias Clin. Cancer Res. 10 2004 4089 4095
6. S.M. Chambers, C.A. Fasano, E.P. Papapetrou, M. Tomishima, M. Sadelain, and L. Studer Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nat. Biotechnol. 27 2009 275 280
7. S. Chang, R.H. Wang, K. Akagi, K.A. Kim, B.K. Martin, L. Cavallone, D.C. Haines, M. Basik, P. Mai, E. Poggi Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155 Nat. Med. 17 2011 1275 1282
8. K.A. D'Amour, A.D. Agulnick, S. Eliazer, O.G. Kelly, E. Kroon, and E.E. Baetge Efficient differentiation of human embryonic stem cells to definitive endoderm Nat. Biotechnol. 23 2005 1534 1541
9. K.A. D'Amour, A.G. Bang, S. Eliazer, O.G. Kelly, A.D. Agulnick, N.G. Smart, M.A. Moorman, E. Kroon, M.K. Carpenter, and E.E. Baetge Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells Nat. Biotechnol. 24 2006 1392 1401
10. R. Drmanac, A.B. Sparks, M.J. Callow, A.L. Halpern, N.L. Burns, B.G. Kermani, P. Carnevali, I. Nazarenko, G.B. Nilsen, and G. Yeung Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays Science 327 2010 78 81
11. R.M. Drost, and J. Jonkers Preclinical mouse models for BRCA1-associated breast cancer Br. J. Cancer 101 2009 1651 1657
12. R. Drost, P. Bouwman, S. Rottenberg, U. Boon, E. Schut, S. Klarenbeek, C. Klijn, I. van der Heijden, H. van der Gulden, and E. Wientjens BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance Cancer Cell 20 2011 797 809
13. F. Elstrodt, A. Hollestelle, J.H. Nagel, M. Gorin, M. Wasielewski, A. van den Ouweland, S.D. Merajver, S.P. Ethier, and M. Schutte BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants Cancer Res. 66 2006 41 45
14. B. Evers, and J. Jonkers Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects Oncogene 25 2006 5885 5897
15. P.A. Futreal, Q. Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L.M. Bennett, A. Haugen-Strano, J. Swensen, and Y. Miki BRCA1 mutations in primary breast and ovarian carcinomas Science 266 1994 120 122
16. F. González, D. Georgieva, F. Vanoli, Z.D. Shi, M. Stadtfeld, T. Ludwig, M. Jasin, and D. Huangfu Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state Cell Rep. 3 2013 651 660
17. P.C. Gordge, M.J. Hulme, R.A. Clegg, and W.R. Miller Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue Eur. J. Cancer 32A 1996 2120 2126
18. A. Gore, Z. Li, H.L. Fung, J.E. Young, S. Agarwal, J. Antosiewicz-Bourget, I. Canto, A. Giorgetti, M.A. Israel, and E. Kiskinis Somatic coding mutations in human induced pluripotent stem cells Nature 471 2011 63 67
19. E.M. Griner, and M.G. Kazanietz Protein kinase C and other diacylglycerol effectors in cancer Nat. Rev. Cancer 7 2007 281 294
20. D.T. Haile, and J.D. Parvin Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain J. Biol. Chem. 274 1999 2113 2117
21. H. Hong, K. Takahashi, T. Ichisaka, T. Aoi, O. Kanagawa, M. Nakagawa, K. Okita, and S. Yamanaka Suppression of induced pluripotent stem cell generation by the p53-p21 pathway Nature 460 2009 1132 1135
22. A.A. Horwitz, S. Sankaran, and J.D. Parvin Direct stimulation of transcription initiation by BRCA1 requires both its amino and carboxyl termini J. Biol. Chem. 281 2006 8317 8320
23. A.M. Hosey, J.J. Gorski, M.M. Murray, J.E. Quinn, W.Y. Chung, G.E. Stewart, C.R. James, S.M. Farragher, J.M. Mulligan, and A.N. Scott Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer J. Natl. Cancer Inst. 99 2007 1683 1694
24. N. Isakov, and A. Altman PKC-theta-mediated signal delivery from the TCR/CD28 surface receptors Front. Immunol. 3 2012 273
25. J. Ji, S.H. Ng, V. Sharma, D. Neculai, S. Hussein, M. Sam, Q. Trinh, G.M. Church, J.D. McPherson, A. Nagy, and N.N. Batada Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells Stem Cells 30 2012 435 440
26. S. Jones, R.H. Hruban, M. Kamiyama, M. Borges, X. Zhang, D.W. Parsons, J.C. Lin, E. Palmisano, K. Brune, and E.M. Jaffee Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene Science 324 2009 217
27. F.E. Kleiman, F. Wu-Baer, D. Fonseca, S. Kaneko, R. Baer, and J.L. Manley BRCA1/BARD1 inhibition of mRNA 3′ processing involves targeted degradation of RNA polymerase II Genes Dev. 19 2005 1227 1237
28. H. Konishi, M. Mohseni, A. Tamaki, J.P. Garay, S. Croessmann, S. Karnan, A. Ota, H.Y. Wong, Y. Konishi, and B. Karakas Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells Proc. Natl. Acad. Sci. USA 108 2011 17773 17778
29. J.M. Lancaster, R. Wooster, J. Mangion, C.M. Phelan, C. Cochran, C. Gumbs, S. Seal, R. Barfoot, N. Collins, and G. Bignell BRCA2 mutations in primary breast and ovarian cancers Nat. Genet. 13 1996 238 240
30. E. Lim, F. Vaillant, D. Wu, N.C. Forrest, B. Pal, A.H. Hart, M.L. Asselin-Labat, D.E. Gyorki, T. Ward, A. Partanen kConFab Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers Nat. Med. 15 2009 907 913
31. J.P. McPherson, B. Lemmers, A. Hirao, A. Hakem, J. Abraham, E. Migon, E. Matysiak-Zablocki, L. Tamblyn, O. Sanchez-Sweatman, and R. Khokha Collaboration of Brca1 and Chk2 in tumorigenesis Genes Dev. 18 2004 1144 1153
32. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, S. Tavtigian, Q. Liu, C. Cochran, L.M. Bennett, and W. Ding A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
33. N. Miyoshi, H. Ishii, H. Nagano, N. Haraguchi, D.L. Dewi, Y. Kano, S. Nishikawa, M. Tanemura, K. Mimori, and F. Tanaka Reprogramming of mouse and human cells to pluripotency using mature microRNAs Cell Stem Cell 8 2011 633 638
34. O. Momcilovic, L. Knobloch, J. Fornsaglio, S. Varum, C. Easley, and G. Schatten DNA damage responses in human induced pluripotent stem cells and embryonic stem cells PLoS ONE 5 2010 e13410
35. A. Motegi, S. Sakurai, H. Nakayama, T. Sano, T. Oyama, and T. Nakajima PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors Pathol. Int. 55 2005 106 112
36. C. O'Brian, V.G. Vogel, S.E. Singletary, and N.E. Ward Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue Cancer Res. 49 1989 3215 3217
37. W.B. Ou, M.J. Zhu, G.D. Demetri, C.D. Fletcher, and J.A. Fletcher Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors Oncogene 27 2008 5624 5634
38. N. Petrucelli, M.B. Daly, and G.L. Feldman Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2 Genet. Med. 12 2010 245 259
39. J.W. Riggs, B. Barrilleaux, N. Varlakhanova, K. Bush, V. Chan, and P. Knoepfler Induced pluripotency and oncogenic transformation are related processes Stem Cells Dev. 22 2013 37 50
40. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, I. Fan, J. Tang, S. Li, S. Zhang, P.A. Shaw, and S.A. Narod Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada J. Natl. Cancer Inst. 98 2006 1694 1706
41. T.S. Ross Grace Rock's consent Endocr. Relat. Cancer 19 2012 C29 C31
42. S. Ruiz, A. Gore, Z. Li, A.D. Panopoulos, N. Montserrat, H.L. Fung, A. Giorgetti, J. Bilic, E.M. Batchelder, and H. Zaehres Analysis of protein-coding mutations in hiPSCs and their possible role during somatic cell reprogramming Nat. Commun. 4 2013 1382
43. B.P. Schlegel, V.J. Green, J.A. Ladias, and J.D. Parvin BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10alpha in activated transcription Proc. Natl. Acad. Sci. USA 97 2000 3148 3153
44. R. Shakya, L.J. Reid, C.R. Reczek, F. Cole, D. Egli, C.S. Lin, D.G. deRooij, S. Hirsch, K. Ravi, and J.B. Hicks BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity Science 334 2011 525 528
45. S.M. Sy, M.S. Huen, and J. Chen PALB2 is an integral component of the BRCA complex required for homologous recombination repair Proc. Natl. Acad. Sci. USA 106 2009 7155 7160
46. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
47. N. Turner, A. Tutt, and A. Ashworth Hallmarks of 'BRCAness' in sporadic cancers Nat. Rev. Cancer 4 2004 814 819
48. L. Warren, P.D. Manos, T. Ahfeldt, Y.H. Loh, H. Li, F. Lau, W. Ebina, P.K. Mandal, Z.D. Smith, and A. Meissner Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA Cell Stem Cell 7 2010 618 630
49. N.A. Wong, and G. Shelley-Fraser Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour Histopathology 57 2010 250 258